Astrazeneca plc - ADR
NASDAQ:AZN 4:00:00 PM EDT
| Market Cap (Intraday) | 201.69B |
| Current PE | 98.63 |
| Forward PE | 19.39 |
| 2yr Forward PE | 17.71 |
| 10-Day MA | $67.29 |
| 50-Day MA | $68.16 |
| 200-Day MA | $64.01 |
Astrazeneca plc - ADR Stock, NASDAQ:AZN
Cambridge Biomedical Campus, 1 Francis Crick Avenue, Cambridge, Cambridgeshire CB2 0AA
Phone: +44.20.3749.5000
Number of Employees: 83100
Description
AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. It focuses on the discovery, development, and commercialization of prescription medicines in Oncology and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. These pharmaceutical products are then manufactured, marketed and sold. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.